Navigation Links
Novel Mechanism Insights and Additional Data on CombinatoRx Drug,Candidates to Be Presented at Upcoming EULAR Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 6, 2007 - CombinatoRx, Incorporated (NASDAQ: CRXX), today announced that data from its randomized, blinded, placebo-controlled phase 2 clinical trials of CRx-102 in patients with osteoarthritis (OA) and rheumatoid arthritis (RA) will be featured at the European League against Rheumatism (EULAR) Annual Congress of Rheumatology meeting, June 13-16, 2007 in Barcelona, Spain.

Schedule of Events:

-- Satellite Symposium, Room 111, Thursday, June 14, 2007 8:15-9:45am

"Novel Approaches to Improve Treatment Outcomes in Arthritis"

Co-Chairs: Steven Abramson, MD, Professor, Medicine and Pathology, Hospital for Joint Diseases, New York, NY and Josef Smolen, MD, Professor, Rheumatology, Medical University of Vienna, Vienna, Austria.

-- Poster #THU0051, Thursday, June 14, 2007, 11:45-1:30pm

"Inhibition of Macrophage and Chrondrocyte Inflammatory Mediators by CRx-102, a Novel Synergistic Combination Drug Candidate", Fraser, et.al.

-- Poster #SAT0236, Saturday, June 16, 2007, 10:15-11:45am

"Response and State-Attainment Criteria in Hand OA: Analyses from a Placebo-Controlled Clinical Trial of CRx-102, a Novel Synergistic Combination Therapy", Kvien, et.al.

-- Poster #SAT0049, Saturday, June 16, 2007, 10:15-11:45am

"A Phase 2a Trial to Evaluate CRx-102 for the Treatment of Active Rheumatoid Arthritis", Kirwan, et.al.

Abstracts are currently available online via the EULAR website (www.EULAR.org) and the posters will be available on the CombinatoRx website (www.combinatorx.com) following presentation.

About CRx-102

CRx-102 is an oral synergistic combination drug candidate containing the cardiovascular agent dipyridamole and an unconventionally low dose of the steroid prednisolone. CRx-102 works through a novel mechanism of action in which dipyridamole selectively amplifies prednisolone's anti-inflammatory and
'"/>




Page: 1 2 3

Related medicine technology :

1. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
2. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
3. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
4. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
7. Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis
8. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
9. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
10. Clinical Data on ARIADs Novel mTOR Inhibitor, AP23573, To Be Presented at the ASCO Annual Meeting
11. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
Post Your Comments:
(Date:7/7/2015)... --  Bionik Laboratories Corp. (OTCBB: BNKL), a ... focus in robotic exoskeleton technology for users with ... that it has completed an additional sale to ... common stock and warrants for aggregate gross proceeds ... transaction.  This equity financing is the sixth and ...
(Date:7/7/2015)... 2015 Oasmia Pharmaceutical AB, ... within human and veterinary oncology, today announced that ... the United States , designed to ... animal therapeutic.      (Logo: http://photos.prnewswire.com/prnh/20150420/740096) , ... , Paccal Vet-CA1 was previously distributed ...
(Date:7/7/2015)... 2015  Monopar Therapeutics LLC, an emerging biopharmaceutical company ... co-founder and CEO, Chandler D. Robinson MD, ... Entrepreneurial Award. The British Council selected one recipient from ... India , and the United States ... entrepreneurs who have leveraged their U.K. education in their ...
Breaking Medicine Technology:Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3Oasmia Pharmaceutical Launches US Brand and Sales Platform 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3
... (Prime), a thought leader in pharmacy benefit management, has ... 2011 Transparency in Pharmaceutical Purchasing Standards(SM) (TIPPS) certification from ... year that Prime has received this certification. ... (PBMs) that have agreed to provide pharmacy cost information ...
... Oct. 19 Ingenuity® Systems, the leading provider ... TransMed Systems, a translational medicine software and services ... and XB Bio-Integration Suite (XB-BIS).  Researchers can now ... managed and statistically analyzed by XB-BIS, directly into ...
Cached Medicine Technology:Prime Therapeutics Receives 2011 TIPPS Certification 2Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research 2
(Date:7/7/2015)... Madison Wisconsin (PRWEB) , ... July 07, 2015 , ... ... 2015 Best of Madison winners in the home service category. This honor can only ... popularity is growing because of the safety of the products and methods they use ...
(Date:7/7/2015)... ... 2015 , ... Difass USA, a modern supplement brand committed to excellence, understands ... work is knowing that there is hopefully a vacation to look forward to this ... Planning for a vacation can be quite stressful, and it’s difficult sometimes to fully ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... highlights rumors about possible facial rejuvenation that have emerged about Hillary Clinton. Two ... Secretary of State looks more youthful than she has in some time and ...
(Date:7/7/2015)... York, NY (PRWEB) , ... July 07, 2015 , ... ... the email newsletter and website that helps active people find the most fun activities ... and active lifestyle coverage for millennials. It also increases Greatist’s opportunity for events, e-commerce, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois cannabis cultivation centers and ... permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and its members ... committed to making sure patients have access to cannabis as a viable medical ...
Breaking Medicine News(10 mins):Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2
... S.C., Nov. 12 What does a,thirty-nine foot Airstream ... cancer? For more than 800 midlands, men last month, ... risk for the disease. The Drive Against Prostate ... for prostate cancer. Doctors Care and WIS-TV,sponsored The Drive ...
... DALLAS, Nov. 12 Hurley Medical Center, a ... physician referral and,class registration services so they will ... a day, seven days a week. The medical ... healthcare-exclusive customer,interaction center, as its partner to provide ...
... Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Pharma,Holdings, Inc. ("China Pharma") ... host a conference call at 11:00 a.m. EST on ... quarter of 2007. Joining Ms. Zhilin Li, President ... Chief Financial Officer. The Company plans to release its,earnings ...
... might keep participants from trials , , MONDAY, Nov. 12 (HealthDay ... trial may have placed participants at higher risk of infection ... the case remains unclear. , What is clear ... would-be trial participants away from future AIDS vaccine studies. , ...
... ), the most advanced method of massage,aromatherapy and ... retained one of Florida,s fastest growing PR firms, ... experience on,the planet. "We see the SpaCapsule(R) ... matter,of minutes can take you from planet stress ...
... the Nation,s Premier Centers for Medical ... Education will Host, Live call-in format will ... Nov. 12 SIRIUS Satellite Radio,(Nasdaq: SIRI ) ... Radio Powered by NYU Medical Center," an exclusive, pioneering,24/7 ...
Cached Medicine News:Health News:UCI Medical Affiliates, Inc. Sponsors Doctors Care Record-breaking Drive Against Prostate Cancer 2Health News:Hurley Medical Center Enhances Customer Service Capabilities With Beryl Partnership 2Health News:China Pharma Holdings, Inc. Announces Conference Call to Discuss Third Quarter 2007 Results 2Health News:Fallout From Failed AIDS Vaccine Could Dampen Research 2Health News:Fallout From Failed AIDS Vaccine Could Dampen Research 3Health News:Fallout From Failed AIDS Vaccine Could Dampen Research 4Health News:The Ultimate Stress Reliever, SpaCapsule(R), the Capsule that Takes You on a Rejuvenating Journey to the Spa, Retains TransMedia Group for Soothing PR 2Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 2Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 3Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 4Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 5
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Inquire...
... Hamilton is precision, ergonomics, and value!, ... fatigue with soft non-slip, contoured handle ... smooth, light plunger spring action , ... sterilization without the need for recalibration ...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: